PH31621A - Pharmaceutical compositions. - Google Patents

Pharmaceutical compositions.

Info

Publication number
PH31621A
PH31621A PH45577A PH45577A PH31621A PH 31621 A PH31621 A PH 31621A PH 45577 A PH45577 A PH 45577A PH 45577 A PH45577 A PH 45577A PH 31621 A PH31621 A PH 31621A
Authority
PH
Philippines
Prior art keywords
pharmaceutical compositions
psoriasis
malignant
esters
salts
Prior art date
Application number
PH45577A
Other languages
English (en)
Inventor
Bollag Werner
Grippo Joseph Francis
Levin Arthur
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH31621A publication Critical patent/PH31621A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
PH45577A 1992-01-22 1993-01-19 Pharmaceutical compositions. PH31621A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82374192A 1992-01-22 1992-01-22
US82378692A 1992-01-22 1992-01-22
US82392892A 1992-01-22 1992-01-22
US82464792A 1992-01-23 1992-01-23

Publications (1)

Publication Number Publication Date
PH31621A true PH31621A (en) 1999-01-12

Family

ID=27505866

Family Applications (1)

Application Number Title Priority Date Filing Date
PH45577A PH31621A (en) 1992-01-22 1993-01-19 Pharmaceutical compositions.

Country Status (20)

Country Link
EP (1) EP0552624B1 (fr)
JP (1) JP3631259B2 (fr)
CN (2) CN1068200C (fr)
AT (1) ATE194077T1 (fr)
AU (1) AU667864B2 (fr)
CA (1) CA2087251C (fr)
CY (1) CY2251B1 (fr)
CZ (1) CZ282548B6 (fr)
DE (1) DE69328910T2 (fr)
DK (1) DK0552624T3 (fr)
ES (1) ES2148184T3 (fr)
GR (1) GR3034323T3 (fr)
HU (2) HU212734B (fr)
IL (1) IL104450A (fr)
NO (1) NO302274B1 (fr)
NZ (1) NZ245686A (fr)
PH (1) PH31621A (fr)
PT (1) PT552624E (fr)
RU (1) RU2119333C1 (fr)
TW (1) TW226329B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968989A (en) 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
ES2066750T3 (es) 1991-12-18 1998-07-01 Salk Inst For Biological Studi Metodo para la modulacion de procesos mediatizados por receptores de retinoides y compuestos de utilidad en dicho metodo.
US7056954B2 (en) 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5962731A (en) * 1992-04-22 1999-10-05 Ligand Pharmaceuticals Incorporated Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US5549888A (en) * 1994-01-31 1996-08-27 Procter & Gamble Aqueous topical anti-acne compositions of low pH
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
US5821254A (en) * 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
US5807900A (en) * 1995-03-31 1998-09-15 Hoffmann-La Roche, Inc. Method for identifying compounds having increased activity for the repair of skin photodamage
WO1996032935A1 (fr) * 1995-04-21 1996-10-24 Ligand Pharmaceuticals Incorporated Inhibition de l'apoptose dans des cellules exprimant le ligand de fas suite a l'activation
DE19523079A1 (de) * 1995-06-26 1997-01-02 Basf Ag Ester und Amide der 9(Z)-Retinsäure
AU7074496A (en) 1995-09-18 1997-04-09 Ligand Pharmaceuticals Incorporated Ppar gamma antagonists for treating obesity
DK0859608T3 (da) * 1995-09-18 2004-06-14 Ligand Pharm Inc Behandling af NIDDM med RXR-agonister
TW442459B (en) * 1996-04-15 2001-06-23 Hoffmann La Roche Retinoid compounds, pharmaceutical composition comprising same and process for the preparation thereof
FR2765480B1 (fr) 1997-07-07 1999-09-10 Oreal Utilisation pour le revetement des matieres keratiniques d'un materiau polymerique hybride ; compositions cosmetiques ou dermatologiques
US7098025B1 (en) 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
AU1707599A (en) * 1998-03-20 1999-10-18 Warner-Lambert Company Retinoid-glitazone combinations
KR100588284B1 (ko) 1999-04-07 2006-06-09 상꾜 가부시키가이샤 아민 유도체 화합물
JP5249484B2 (ja) * 2001-12-11 2013-07-31 第一三共株式会社 医薬組成物
EP1496879A4 (fr) * 2002-04-05 2008-06-18 Univ Utah Res Found Regulation d'une nouvelle desydrogenase de retinol specifique au colon par l'apc et cdx2
WO2004022042A1 (fr) * 2002-09-06 2004-03-18 Oregon Health And Science University Effet d'un gel de vitamine a sur la muqueuse des sinus de la face
EP1527774A1 (fr) 2003-11-03 2005-05-04 Basilea Pharmaceutica AG Formulations nouvelle pour retinoides contenant capsules de gélatine molle
JP4825957B2 (ja) * 2005-03-29 2011-11-30 国立大学法人 鹿児島大学 抗腫瘍剤
KR101710505B1 (ko) 2009-09-15 2017-02-27 노벨리언 테라퓨틱스 인코포레이티드 리피드 비히클에 9-시스-레티닐 에스테르를 포함하는 약제 처방
SG184901A1 (en) * 2010-04-16 2012-11-29 Davos Life Science Pte Ltd Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications
RU2622763C2 (ru) 2010-04-19 2017-06-19 Новелион Терапьютикс Инк. Лечебная схема и способы лечения или уменьшения нарушений зрения, связанных с дефицитом эндогенных ретиноидов
BR112014021602A2 (pt) 2012-03-01 2021-06-08 Quadra Logic Tech Inc uso, kit e derivado de retinal sintético para melhorar a função visual em distúrbios visuais associados com a deficiência de produção endógena de retinóide
JP6182728B2 (ja) * 2012-11-02 2017-08-23 国立大学法人名古屋大学 幹細胞を標的とした薬効及び毒性の評価法
WO2022051831A1 (fr) 2020-09-11 2022-03-17 Chemyunion Ltda. Composition, utilisation de cette composition, procédé cosmétique et procédé pour moduler la production de sébum
WO2023168608A1 (fr) * 2022-03-08 2023-09-14 Mastery Biotech Co., Ltd. Composition pharmaceutique comprenant de l'acide rétinoïque et un glucide et son utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
DE3853427T2 (de) * 1987-04-06 1995-12-14 Daltex Medical Sciences Inc Behandlung gealterter haut mit oraler 13-cis-retinsäure.
US4994491A (en) * 1988-12-14 1991-02-19 Molecular Design International Dermal uses of trans-retinoids for the treatment of cancer
LU86969A1 (fr) * 1987-08-12 1989-03-08 Oreal Association de derives de pyrimidine et de retinoides en composants separes pour induire et stimuler la croissance des cheveux et diminuer leur chute
ES2066750T3 (es) * 1991-12-18 1998-07-01 Salk Inst For Biological Studi Metodo para la modulacion de procesos mediatizados por receptores de retinoides y compuestos de utilidad en dicho metodo.

Also Published As

Publication number Publication date
AU3186193A (en) 1993-07-29
TW226329B (fr) 1994-07-11
DE69328910T2 (de) 2001-01-11
CA2087251A1 (fr) 1993-07-23
ATE194077T1 (de) 2000-07-15
DE69328910D1 (de) 2000-08-03
NZ245686A (en) 1995-05-26
HU211167A9 (en) 1995-11-28
GR3034323T3 (en) 2000-12-29
CA2087251C (fr) 2003-06-24
JPH06107542A (ja) 1994-04-19
CY2251B1 (en) 2003-07-04
HU9300116D0 (en) 1993-04-28
AU667864B2 (en) 1996-04-18
DK0552624T3 (da) 2000-09-25
HU212734B (en) 1996-10-28
IL104450A0 (en) 1993-05-13
ES2148184T3 (es) 2000-10-16
CN1256916A (zh) 2000-06-21
RU2119333C1 (ru) 1998-09-27
NO930206D0 (no) 1993-01-21
CN1155376C (zh) 2004-06-30
EP0552624B1 (fr) 2000-06-28
IL104450A (en) 1997-03-18
CN1074826A (zh) 1993-08-04
NO930206L (no) 1993-07-23
EP0552624A1 (fr) 1993-07-28
HUT63053A (en) 1993-07-28
NO302274B1 (no) 1998-02-16
CZ282548B6 (cs) 1997-08-13
PT552624E (pt) 2000-10-31
CN1068200C (zh) 2001-07-11
JP3631259B2 (ja) 2005-03-23
CZ372892A3 (en) 1993-12-15

Similar Documents

Publication Publication Date Title
PH31621A (en) Pharmaceutical compositions.
RU93005355A (ru) Фармакологические композиции
AU2080988A (en) Esters of 13-trans-retinoic acid
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
AU5471190A (en) Method of topically treating acne vulgaris
MD921G2 (ro) Derivaţi arilpropionici, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
IT1223290B (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
ATE161419T1 (de) Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
AU6333794A (en) Retinoid composition
KR930016100A (ko) 약제학적 조성물
DE3485337D1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
HK1004917A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
TR199700694T1 (xx) D vitamini t�revlerinin dermotolojik kullan�m�.
IT1261696B (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ATE113209T1 (de) Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten.
IE873478L (en) Use of 13-cis retinoic acid
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
IT1242478B (it) Composizioni farmaceutiche ad attivita' depigmentante e contro il danneggiamento cutaneo fotoindotto.
FI910308A0 (fi) Vattenloesliga vitamin a preparationer foer applicering pao huden.
CA2062422A1 (fr) Methode pour le traitement des patients presentant des lesions precancereuses par l'administration d'acides sulfonylindenylacetiques et sulfonylindenylpropioniques et leurs esters